RPRX

Royalty Pharma plc

1 day chart

About RPRX

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on more than 35 commercial products, including Vertexs Trikafta, Kalydeco, Orkambi and Symdeko, Biogens Tysabri, AbbVie and Johnson & Johnsons Imbruvica, Astellas and Pfizer's Xtandi, GSKs Trelegy, Novartis Promacta, Pfizer's Nurtec ODT, Johnson & Johnsons Tremfya, Roches Evrysdi, Gilead's Trodelvy, and 12 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Olpasiran, Omecamtiv mecarbil, Pelabresib, Pelacarsen, Seltorexant, Trontinemab, Tulmimetostat and Zavegepant. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.

Buy US stocks in Australia starting with RPRX. Open an account and start investing today!

Market Capitalisation

$19.66B

Price-earnings ratio

Dividend yield

2.47%

Volume

2.83M

High today

$32.77

Low today

$32.17

Open price

$32.48

52-week high

$44.66

52-week low

$32.02

RPRX FAQs

Can I buy RPRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy RPRX shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Royalty Pharma plc?

One share of Royalty Pharma plc is valued at $32.45.

What is the ticker symbol for Royalty Pharma plc?

The ticker symbol for Royalty Pharma plc is RPRX.

How do I buy RPRX shares in Australia?

To buy RPRX stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in RPRX

What is the 52-week high for Royalty Pharma plc stock?

The Royalty Pharma plc 52-week high stock price is $44.66.

What is the 52-week low for Royalty Pharma plc stock?

The Royalty Pharma plc 52-week low stock price is $32.02.

What is the market capitalisation of Royalty Pharma plc RPRX?

As of 31/05/2023 Royalty Pharma plc has a market cap of $20B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.